Apyx Medical Corp

Apyx Medical Corp

Apyx Medical Corp, trading under APYX, operates in the Surgical & Medical Instruments & Apparatus realm where innovators work to lower invasive procedure risks; the company’s portfolio stretches from radiofrequency-based Precision devices to advanced energy delivery systems designed for surgeons and hospitals seeking optimized treatment outcomes across anatomy reduction and wound management use cases. The business leans on sterile, single-use offerings plus reusable generators that appeal to ambulatory surgery centers, integrated health systems, and specialist physician groups pursuing faster recoveries and predictable clinical results. Like others in the SIC 3841 cluster, it navigates complex FDA clearance pathways, reimbursement shifts, and global supply-chain scrutiny, with material risks stemming from regulatory delays, litigation over Claims of product efficacy, and potential cost pressures from shifting healthcare budgets. CIK 719135 surfaced again with a Form 8-K filed Nov 2025 to highlight recent leadership or strategic moves, so view live SEC filings on Earnings Feed.